Advances in diagnosis and treatment of thymic carcinoid
10.3969/j.issn.1001-6325.2017.11.030
- VernacularTitle:胸腺类癌诊断及治疗策略进展
- Author:
xin Nai LIANG
1
;
Luo ZHAO
;
qing Shan LI
Author Information
1. 中国医学科学院北京协和医学院北京协和医院胸外科
- Keywords:
thymic carcinoid;
diagnosis and treatment strategy;
Ki67 index
- From:
Basic & Clinical Medicine
2017;37(11):1644-1648
- CountryChina
- Language:Chinese
-
Abstract:
Thymic carcinoid is a rare neoplasm with unclear risk factors and controversial classifications .Clinical manifestations vary from asymptomatic to many nonspecific symptoms , among which endocrinopathy seems to be as-sociated with poor prognosis .Image studies show no specificity both in CT and PET/CT, but are of great value in clinical staging .Ki67 index has been found to be a powerful tool for grading neuroendocrine tumors and further studies should be made .The diagnosis of thymic carcinoid mainly depends on pathology and immunohistochemistry plays a role in differential diagnosis .Radical resection is the first choice in treatment , and target therapy becomes possible with the development in molecular pathology .
